Skip to main content
. 2022 Oct 7;13:974346. doi: 10.3389/fimmu.2022.974346

Figure 1.

Figure 1

(A) Immune cell score, stromal cell score, combined scores of immune and stromal cells, and tumor purity in the high- and low-immunity groups. (B) The relationships between the immune score and different immunity groups. (C) The differences in TP53I13 expression in the high- and low-immunity groups.